Chimeric Therapeutics (CHM AU)

Analysis

Health Care • Australia

Chimeric Therapeutics Limited operates as a biotechnology company. The Company develops CAR T cell therapies for solid tumors based on research at the City of Hope Cancer Centre in Los Angeles. Chimeric Therapeutics serves customers worldwide.

Refresh

Company Event • 27 Feb 2026 07:00 • Upcoming

Add To Calendar

H1 2026

Company Event • 08 Oct 2025 08:00 • Latest

Investor Update

Company Event • 09 Sep 2025 08:00

Study Update

Company Event • 29 Aug 2025 06:00 • Upcoming

Add To Calendar

H2 2025

Company Event • 04 Aug 2025 06:00 • Upcoming

Add To Calendar

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00